Tag Archives: gild

Video: Gilead OKs Generic Sovaldi To Expand Access

Big-cap biotech and IBD 50 stock Gilead Sciences (GILD) said Monday that it’s licensing its megablockbuster hepatitis C drug Sovaldi to seven Indian generic-drug companies to improve access in 91 developing countries. Gilead’s stock fell about 2% on the stock market today. The Sovaldi licensing deal includes the big names in the Indian drug business, such as Ranbaxy Labs and Cipla, as well as U.S.-based Mylan (MYL). The drugmakers will be able to

Gilead OKs Generic Sovaldi To Expand Global Access

Big-cap biotech and IBD 50 stock Gilead Sciences (GILD) said Monday that it’s licensing its megablockbuster hepatitis C drug Sovaldi to seven Indian generic-drug companies to improve access in 91 developing countries. Gilead’s stock fell about 2% on the stock market today. The Sovaldi licensing deal includes the big names in the Indian drug business, such as Ranbaxy Labs and Cipla, as well as U.S.-based Mylan (MYL). The drugmakers will be able to

Why Gilead Is Falling On Drugs For Developing Nations

Shares of Gilead Sciences (GILD) are down amid news that the drugmaker is reportedly nearing a licensing deal to bring its blockbuster hepatitis C drug Sovaldi to developing countries such as India and Pakistan. Generic drugmakers would be able to manufacture the best-selling hepatitis C therapy as well as an experimental Sovaldi hybrid, according to Bloomberg. Pricing is a sore spot for Gilead, as much has been made about the drug’s $1,000-a-pill